射频消融联合肝切除与单纯肝切除治疗结直肠癌肝转移的远期结局
该研究纳入553例因结直肠癌肝转移行首次肝切除的患者,其中37例接受肝切除联合射频消融(RFA),516例接受单纯肝切除,经倾向性评分匹配后比较31例联合组与93例单纯组。结论认为联合RFA可获得与单纯肝切除相当的结果,可考虑作为实现治愈的选择。
要点
- 肝切除联合RFA与单纯肝切除的5年总生存和无病生存无显著差异
- 联合组总体局部复发更常见,但肝内无病生存无差异
- 消融部位局部复发率为13%,联合RFA可作为实现治愈的选项
核心结论
- 肝切除联合RFA治疗结直肠癌肝转移可获得与单纯肝切除相当的远期结局。
- 联合RFA应被视为实现治愈的一种选择。
研究设计与样本
- 回顾性队列研究,纳入2001至2012年间因结直肠癌肝转移行首次肝切除的患者。
- 共553例患者,其中肝切除联合RFA组37例,单纯肝切除组516例。
- 采用倾向性评分匹配,将31例联合组患者与93例单纯组患者进行匹配比较。
主要发现
- 匹配前,联合RFA组患者主要特征为肿瘤负荷更大。
- 匹配后两组背景特征均衡良好。
- 消融部位局部复发见于31例中的4例(13%)。
临床怎么用
- 对于结直肠癌肝转移患者,肝切除联合RFA可作为实现治愈的治疗选项。
- 联合RFA后需关注局部复发风险,尤其是消融部位和切面。
局限性
- 联合RFA组样本量较小(匹配后31例),可能影响统计效能。
- 为回顾性研究,存在选择偏倚可能,尽管使用了倾向性评分匹配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Combining radiofrequency ablation (RFA) with hepatectomy may enable treatment with curative intent for patients with colorectal liver metastasis (CRLM). However, the oncological outcomes in comparison with resection alone remain to be clarified. METHODS: Patients who underwent a first hepatectomy between 2001 and 2012 for CRLM were enrolled. Short- and long-term outcomes of patients who underwent hepatectomy plus RFA were compared with those of patients who had hepatectomy alone using propensity score matching. RESULTS: Of a total of 553 patients, hepatectomy + RFA and hepatectomy alone were performed in 37 and 516 respectively. Before matching, patients in the hepatectomy + RFA group were characterized primarily by a larger tumour burden. After matching of 31 patients who underwent hepatectomy + RFA with 93 who had hepatectomy alone, background characteristics were well balanced. In the matched cohort, overall and disease-free survival in the hepatectomy + RFA group were no different from those among patients who had hepatectomy alone (5-year overall survival rate 57 versus 61 per cent, P = 0·649; 5-year disease-free survival rate 19 versus 17 per cent, P = 0·865). Local recurrence at the ablated site was observed in four of 31 patients (13 per cent). Although overall local recurrence (ablated site and/or cut surface) was more frequent in the hepatectomy + RFA group (9 of 31 (29 per cent) versus 11 of 93 (12 per cent); P = 0·032), there was no difference in intrahepatic disease-free survival between the two groups (P = 0·705). CONCLUSION: Hepatectomy + RFA achieved outcomes comparable to hepatectomy alone. Combining RFA with hepatectomy should be considered as an option to achieve cure.
引用
- Imai K, Allard MA, Castro Benitez C, et al. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. Br J Surg. 2017. PMID: 28112813. doi:10.1002/bjs.10447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。